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ABSTRACT 
 
Aim: Solenostemon monostachyus (P.Beauv.) Briq.(SE) is the object of our investigation test the 
mechanism of its anti-oxidative action to  further establish its anti-sickling properties..  
Sample: To correlate hematological parameters and antioxidant activities with the presence induced 
hemolytic anemia in female rats to validate other screening parameters. 
Place and Duration of Study: The study as carried out in the covenant university animal house 
and biochemistry laboratory, department of biological sciences, covenant university. sample: the 
animals were obtained from the Institute for advanced medical research and training (IMRAT), 
college of medicine, UCH, Orita-mefa, Ibadan, Oyo state and allowed to acclimatize under a 12-hour 
light/dark cycle for 3 weeks prior to the commencement of the study between January 2015 and 
Original Research Article 
 
 
 
 
Osikoya et al.; IJBCRR, 18(4): 1-11, 2017; Article no.IJBCR.35719 
 
 
 
2 
 
February 2015. 
Methodology: 2-Butoxyethanol was used to induce hemolytic anemia resembling that of sickle cell 
disease. The methanolic extract of the leaves was orally administered for 5 days at 150 mg/kg, 200 
mg/kg and 250 mg/kg of body weight doses to determine the antioxidant activities and some 
hematological indices of plasma in the kidney, spleen and liver of 2-butoxyethanol hemolytic-
induced rats. Sample: we used 49 Wistar albino rats (49 female; weight: 95-120 g). Hematological 
examination (PCV, MCV, RBCs, and hemoglobin [Hb] count) and sICAM levels was done besides 
antioxidant activities (bilirubin, glutathione, superoxide dismutase, TBARS and peroxidase). Weight 
of the animals was also calculated. 
Results: The results were analyzed using ANOVA. The result of the oxidative stress markers 
showed that SOD, TBARS and peroxidase were insignificant (P>0.05) in the kidney, liver and 
spleen of all the rats while GSH  in the kidney and liver insignificantly high in the SM-treated rats 
while GSH in the spleen was significantly increased in SM-150 (7.67±2.19) compared to control. 
Conclusion: These doses have shown that they can be used alongside other drugs to alleviate 
oxidative stress in hemolytic anemic related diseases such as sickle cell disease. 
These predictors, however, need further work to validate reliability. 
 
 
Keywords: Plant; Solenostemon monostachyus; hemolysis; anemia; antioxidant; inflammation. 
 
ABBREVIATIONS 
 
SM-150 : Group orally administered 150 mg/kg 
extract of Solenostemon 
monostachyus;  
SM-200 :  Group orally administered 200 mg/kg 
extract of Solenostemon 
monostachyus;  
SM-250 :  Group orally administered 250 mg/kg 
extract of Solenostemon 
monostachyus;  
2BE :  2-Butoxyethanol;  
2-BEA :  2-BE induced hemolysis;  
CF-A :  Caffeic acid;  
CKV :  Ciklavit;  
sICAM :  Soluble intracellular adhesion 
molecule. 
 
1. INTRODUCTION  
 
Anemia is a common blood disorder affecting 
people of all ages and posing a great threat to 
global healthcare [1]. According to the World 
Health Organization, about 30 percent of people 
throughout the world suffer from anemia with 
sickle cell anaemia affecting 1.3-1.8% of the 
Nigerian population [2]. Exposure to many 
chemicals including the administration of some 
drugs has been associated with red blood cell 
destruction [3], and haemolyticanaemia is a part 
of the clinical syndrome associated with 
intoxication. Chemicals can cause hemolysis by 
interacting with sulfhydryl groups, the inhibition of 
various enzymes, immune mechanisms, and the 
fragmentation of erythrocytes as they pass 
through the platelet-fibrin mesh or by unknown or 
poorly defined mechanisms. 
2-Butoxyethanol (BE; ethylene glycol monobutyl 
ether) is widely used as a solvent in surface 
coatings, such as spray lacquers, varnishes, 
varnish removers, and latex paint [4,5]. 2-
Butoxyethanol is also used as a coupling agent 
in metal and household cleaners; as an 
intermediate in 2-butoxyethanol acetate 
production; and in herbicides, automotive brake 
fluids, printing inks, spot removers, and 
cosmetics [6]. 2-Butoxyethanol is readily 
absorbed following inhalation, oral, and dermal 
exposure.  Female rats developed disseminated 
thrombosis and bone infarction following 
inhalation exposure to 2-BE [7]. The principal 
effect exerted by 2-butoxyethanol and its 
metabolite 2-butoxyacetic acid is 
haematotoxicity, with the rat being the most 
sensitive species. It is documented that 2-BE 
causes acute hemolytic anemia in male and 
female rats and that metabolic activation of 2-BE 
to 2-butoxyacetic acid (BAA) is required for the 
manifestation of this effect [8,9,10,11]. Previous 
studies showed that the haematologic effects (i.e 
reduction in erythrocytic number, haematocrit 
and haemoglobin levels) are more severe in 
female than in male rats when using comparable 
dosage [8,11]. The effects of 2-BE on red blood 
cell parameters are time and dose dependent.  
 
In other investigations, it was shown that daily 
dosing of male rats and 2-BE beyond a period of 
3 days resulted in tolerance to the development 
of haemolyticanaemia [12]. In vivo and in vitro 
investigations of the mechanism(s) underlying 
these phenomena indicated that tolerance may 
be related to the lesser sensitivity of young 
erythrocytes formed during the generative 
process [12,13].  
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Medicinal plants have always been considered 
as a healthy source of life for all people. It has 
been estimated by the World Health Organisation 
that 80% of the world population relies on 
traditional medicine to meet their daily health 
[14]. The Lamiaceae is a commonly encountered 
family, especially in the temperate regions of the 
world. It is comprised of about 3500 species 
distributed among some 200 genera, most of 
these herbaceous, less often shrubs, or rarely 
trees. Some of the species are highly desirable 
cooking herbs or flavour producers. 
Solenostemon monostachyus P. Beauv is the 
object of our investigation to test the antioxidant 
properties in 2-BE induced rats. The leaves of 
this plant serve to cure the female sterility, the 
dysmenorrhoea, the rheumatisms, foot infections 
and snakebites. The roots were used to treat the 
onchocerciasis [15]. The essential oils of the 
leaves contain: β – pinen (13%), oct.-1-en-3-ol 
(12.5%), β – caryophyllen (7%), octan-3-ol (7%) 
and (E,E) - α – farnèsen (6%) as principal 
constituent [16]. Pharmacological investigation 
realized with ethanolic extract confirmed the use 
of the plant’s leaves to treat the convulsions in 
children [17]. Solenostemon monostachyus plant 
at a concentration of 100 μg/ml had a DPPH 
scavenging activity very close to those of gallic 
acid and ascorbic acid thus it possesses strong 
antioxidant properties due to its total phenolics 
contents [17], blood pressure lowering effect [18], 
hydrogen peroxide scavenging potentials [19], in 
vitro anti-sickling effect of S. monostachyus in 
human sickle cell blood has been implicated in 
the alleviation of SCD symptoms [20] and also 
high calcium content [21]. This gives a clue that 
the leaves of Solenostemon monostachyus might 
have good potential as a source for natural 
health products. 
 
This present research was carried out to show 
the safety of Solenostemon monostachyus for 
human use through haematological and 
biochemical study and secondly, to know more 
pharmacological activities of these leaves, 
because of its rich phytochemical constituents. 
 
2. MATERIALS AND METHODS  
 
2.1 Reagents and Chemicals 
 
Rat sICAM-1 ELISA kits, rat COX-2 ELISA kits 
and rat TNF-α ELISA kits were obtained from 
Hangzhou Eastbiopharm Co., Ltd (Yile Road, 
Hangzhou, Zhejiang, China). Rat HO-1 ELISA 
kits were obtained from Cloud-Clone Corp. 
(Houston, USA). Bilirubin and total protein kits 
were obtained from RANDOX Laboratories Ltd. 
(Crumlin, Co. Antrim, United Kingdom), while 
methanol was obtained from British Drug House 
Chemicals Limited (Poole, England). All 
chemicals used in this study were of analytical 
grade. 
 
2.2 Collection of Plant Material  
 
S. monostachyus (P. Beauv) Brig. (Voucher no: 
FHI108913) plants were collected for 2 weeks 
from the lawns of Covenant University, Ota, 
Ogun State. This plant was identified at the 
Applied Biology Unit of the Biological Sciences 
Department at Covenant University. The plant 
samples were reconfirmed and deposited at the 
Herbarium Unit of the Forest Research Institute 
of Nigeria (FRIN), Ibadan, Nigeria. The allocated 
voucher number of the plant deposited at FRIN is 
as indicated above. The collected leaves were 
air-dried at ambient temperature (35–37°C) on 
the laboratory bench. Plants were turned daily to 
accelerate the drying process over a period of 2 
weeks. The dried plants were then blended to a 
coarse powder using a blender. 
 
2.3 Preparation of the Plant Methanolic 
Extract 
 
The methanolic extract of the plants was 
prepared using the method of [22] with 
modifications. A total of 90 g of the plant was 
macerated in 1,200 ml of methanol (BDL 
chemical) for 72 hours at room temperature. The 
resulting mixture was filtered twice using cotton 
wool and Whatman filter paper 1 Cat No 1001 
150 and then evaporated to dryness in vacuo 
with a Stuart rotary evaporator (RE 300) at 20°C. 
A total of 5.0 g of the dried extract was re-
dissolved in 25 ml of absolute methanol. This 
solution was used as the working anti-hemolytic 
agent. 
 
2.4 Handling of Animals and Experi-
mental Design 
 
A total of 49 adult female Wistar albino rats 95-
120 g were used in this study. The animals were 
obtained from the Institute for Advanced Medical 
Research and Training (IART), College of 
Medicine, UCH, Orita-mefa, Ibadan, Oyo State. 
The animals were housed in metabolic cages 
and allowed to acclimatize under a 12-hour 
light/dark cycle for 3 weeks prior to the 
commencement of the study. They were 
maintained on a layer diet (produced by Grace 
Feeds, Ota, Ogun State) and water during the 
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entire period of experimentation. An ethical 
permit (reference number CU/BIOSCRECU/ 
BIO/2015/010) was obtained from the ethics 
committee of our institution prior to beginning the 
study. Handling of the experimental rats was in 
accordance with the ethical procedures 
recommended by the Covenant University 
Ethical Committee. 
 
The animals were randomly classified into the 
following groups, each including 7 animals. The 
control group (C) was orally administered 5 ml of 
normal saline/kg of body weight, and the 
hemolytic anemic group (2-BEA) was orally 
administered 2-BE only to serve as a negative 
control. The positive control group (CF-A) was 
orally administered 10 mg of caffeic acid/kg of 
body weight (caffeic acid a major bioactive 
compound in the studied plant) after inducing 
hemolysis with 2-BE. Treatments 1 (SM-150), 2 
(SM-200) and 3 (SM-250) were orally 
administered 150 mg/kg, 200 mg/kg and 250 
mg/kg of the plant extracts, respectively, 
following the induction of hemolysis by 2-BE 
administration. The standard group (CKV) was 
similarly employed as the treatment group, but 2 
ml of ciklavit/kg of body weight was used in place 
of the extract. Ciklavit is drug manufactured by 
Neimeth International Pharmaceutical Plc., 
Nigeria, for the management of sickle cell 
anemia. 
 
The 2-BE was orally administered to induce 
hemolytic anemia following the method of [23] at 
250 mg/kg of body weight daily for four 
consecutive days. The methanolic extract of S. 
monostachyus plants was also orally 
administered daily at doses of 150 mg/kg, 200 
mg/kg and 250 mg/kg of body weight for five 
days. The body weights were measured, and all 
rats were monitored for abnormal clinical signs 
prior to the administration of 2-BE on day 1 and 
daily thereafter. The rats were observed twice: 2 
hours and 24 hours after each dose. 
 
The 2-BE group was sacrificed immediately after 
administration on the fourth day. Other groups 
were sacrificed after the fifth day of treatment 
under diethyl ether anesthesia in an enclosed 
desiccator. The heart was carefully punctured to 
drain the blood using a syringe. The blood 
samples were collected into EDTA bottles or 
plain bottles, as described by [24]. The blood 
samples in EDTA bottles were used for 
hematological study, and the plasma obtained 
was used for sICAM analysis. The blood samples 
in plain bottles were centrifuged at 10,000 rpm 
for 15 minutes to obtain the serum, which was 
preserved at -20°C for further analyses. The 
livers, kidney and spleen were then excised 
carefully from the root to avoid rupturing the 
organ. The organs were rinsed in cold normal 
saline before preservation. 
 
2.5 Homogenization of Organs 
 
A portion (0.2 g) of each organ was excised, 
weighed and blended in 0.9 ml of homogenizing 
buffer contained in homogenizing tubes. An 
additional 0.9 ml of buffer was used to rinse the 
homogenizer (Emel blender EM-242) per 
sample. The homogenized tissues were 
immediately centrifuged at 3,000 g for 10 min, 
and the supernatants were collected into new 
tubes and preserved at -20ºC for experimental 
purposes. 
 
2.6 Analysis 
 
2.6.1 Procedure for the determination of 
hematological parameters 
 
The hematology parameters (PCV, MCV, RBCs, 
and hemoglobin [Hb]) monitored in this study 
was determined using a Sysmex 8000 
hematology auto-analyzer. 
 
2.6.2 Procedure for the determination of  
bilirubin contents 
 
Direct bilirubin and total bilirubin were 
determined colorimetrically with the aid of a 
Thermo Scientific Evolution 60S UV-Visible 
spectrophotometer 23A09015 following the 
methods described by [25], as indicated in the 
manual provided by the manufacturers of the kit 
(Randox Laboratories Ltd., Crumlin, Co. Antrim, 
United Kingdom). Diazotized sulfanilic acid in 
alkaline medium and caffeine, respectively, were 
used as substrates. Total and direct bilirubin 
contents were calculated from the recorded 
absorbance values using the formulas indicated 
below: 
 
Total bilirubin (mg/dl) = 10.8 * Abs 578 nm; 
Direct bilirubin (mg/ml) = 14.4 * Abs 546 nm. 
 
2.6.3 Procedure for the determination of 
superoxide dismutase activity 
 
Superoxide dismutase activity was determined 
spectrophotometrically using a Thermo Scientific 
Evolution 60S UV-Visible Spectrophotometer 
23A09015, as described by [26]. An increase in 
absorbance at 420 nm over approximately 3 
minutes was observed. The change in 
 
 
 
 
Osikoya et al.; IJBCRR, 18(4): 1-11, 2017; Article no.IJBCR.35719 
 
 
 
5 
 
absorbance (ΔAbs 420 nm/minute) was 
determined using the maximum linear rate for 
both the test and the blank. The inhibition was 
then calculated using the formula presented 
below: 
 
Inhibition (%) = [(Δ Abs 420 nm/min of blank- Δ 
Abs 420 nm/minute of sample * 100/Δ Abs 420 
nm/min of blank)] 
 
2.6.4 Procedure for the determination of lipid 
peroxidation 
 
TBARS was estimated to monitor lipid 
peroxidation according to the method proposed 
by [27]. The absorbance was read at 535 nm 
using the spectrophotometer (Thermo Scientific 
Evolution 60S UV-Visible Spectrophotometer), 
and the concentration was calculated based on 
the observed absorbance using the formula 
below, where the constant (Ƹ) is equal to 1.56 * 
105 m-1 cm-1.  
 
Concentration (m) = Absorbance 
    Ƹ 
 
2.6.5 Procedure for the determination of 
peroxidase activity 
 
The peroxidase activity of the tissue homogenate 
was determined in the absence (blank) and 
presence (sample) of the plant extract according 
to the method described by [28]. The test 
reagents were mixed by inversion, and the rates 
of the change in absorbance at 420 nm per 30 
seconds were determined for both the test and 
blank samples. The activity of the enzyme was 
calculated from the observed change in 
absorbance using the formula provided below: 
 
Units/ml enzyme = [(Δ Abs 420 nm/30 sec of 
sample- Δ Abs 420 nm/30 sec of blank)* df]/12 * 
0.3 
 
where df = the dilution factor, 12 = the millimolar 
extinction coefficient of pyrogallol, and 0.3= the 
volume (ml) of enzyme used. 
 
2.6.6 Procedure for the determination of GSH 
levels 
 
GSH was determined by the method described 
by [29]. GSH reacts with DTNB to produce a 
yellow-colored product that absorbs at 412 nm. 
 
Calculation: 
 
Enzyme content (mmol/g tissue) = 
(Absorbance/14.15) *2.44 *dilution factor 
Where 14.15 mM-1cm-1 is the molar extinction 
coefficient of DTNB and 2.44 is the dilution factor 
of the sample in the 1.22 ml solution assayed. 
 
2.6.7 Procedure for the determination of sI 
CAM levels 
 
The determination of sICAM in serum was 
conducted following the instructions of the ELISA 
kit manual provided by the manufacturer 
(Hangzhou Eastbiopharm, Hangzhou, China; 
Cat. No: CK-E30438). Briefly, 50 μl of standard 
and 50 μl of streptavidin-HRP were loaded into 
the blank well, and 40 μl of sample, 10 μl of 
antibody and 50 μl of streptavidin-HRP were 
loaded into the test wells. The plate was gently 
shaken and incubated at 37 °C for 60 min. The 
plate was then washed with washing buffer five 
times. Fifty-microliter aliquots of chromogens A 
and B were then added to each well, mixed 
gently, and incubated for 10 min at 37 °C in the 
dark. Then, 50 μl of the stop solution was added 
to each well. After 15 min, the optical density was 
measured at 450 nm. The standard curve was 
plotted using Microsoft Excel. 
 
2.7 Statistical Analysis 
 
A one-factor randomized complete block design 
was used for this study. Data were analyzed 
using analysis of variance (ANOVA) in the 
MegaStat statistical software package (version 
1.0.0.0). Treatments with P<0.05 were 
considered statistically significant and were 
subjected to Student’s t-test using the same 
statistical software. The results were expressed 
as mean ± standard deviation. 
 
3. RESULTS AND DISCUSSION 
 
The weight of the animals in the SM-200 group 
significantly increased (P = .05) throughout the 
study period (Table 1). Table 2 shows the levels 
of soluble intracellular adhesion molecule 
(sICAM) and hematological parameters 
considered in this experiment. The PCV in the 
blood of the animals treated with S. 
monostachyus extracts (SM-150 and SM-200) 
was significantly higher (P = .05) than in the 
controls. SM-250 generated the lowest PCV. The 
hemoglobin levels in the rats treated with SM-
150 and SM-200 were significantly increased (P 
= .05), as were those treated with 2BEA and CF-
A, compared to the control and CKV groups 
(Table 2). The level of RBCs was also 
significantly increased (P = .05) by the 
administration of SM-150, SM-200 and CF-A. All 
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of the extracts (i.e., SM-150, SM-200 and SM-
250) significantly increased (P = .05) mean cell 
volume (MCV) in a manner similar to that of CF-
A and CKV compared with the controls (Table 2).  
 
TBARS and Bilirubin were insignificantly different 
(P = .05) compared to control. 
 
Of the three organs examined, only ckv 
significantly increased (p<0.05) total bilirubin in 
the spleen (Tables 2–4). 2bea consistently 
significantly increased (p<0.05) reduced 
glutathione (gsh) activity in the liver (Table 3), 
kidney (Table 4), and spleen (Table 5), while ckv 
significantly reduced (p = .05) the activity of gsh 
in the kidney (Table 4). sm-150 significantly 
increased (p = .05) gsh activity in the spleen 
(Table 5). sm-200, sm-250 and ckv significantly 
increased (p = .05) direct bilirubin in the spleen 
(Table 5). 
 
4. DISCUSSION 
 
In this work, we investigated the antioxidant and 
anti-hemolytic activities of S. monostachyus. We 
recently reported that in addition to its multiple 
health benefits, S. monostachyus treatment 
resulted in 98.1% sickle cell blood reversal in 
humans [20]. Our study provides a clue 
regarding the mode of action of the plant based 
on some hematological and biochemical indices. 
We suggest that this understanding will 
contribute to the development of a permanent 
solution for sickle cell disease and other 
hemolytic-associated diseases. The results from 
the hematology analysis of the blood samples 
from the animals are shown in Table 2. The PCV 
levels were increased by 2BEA and CF-A 
treatments. The PCV levels in the SM-150- and 
SM-200-treated groups increased over those of 
the CKV and control groups. The effect of SM-
250 on PCV levels was similar to that of CKV. 
Additionally, the level of RBCs was increased by 
SM-150, SM-200 and CF-A administration (Table 
2). This ability of S. monostachyus to promote 
blood synthesis may be attributed to the 
presence of iron (95.5 mg/kg dry wt.) and some 
blood-boosting biomolecules in the leaf [30]. 
 
In addition, the hemoglobin level was remarkably 
increased with SM-150, CF-A, 2BEA and SM-
200 administration. This increase has been 
attributed to the release of hemoglobin during 
hemolysis (RBC destruction) resulting from 
exposure to high concentrations of 2BEA [31]. 
The ability to reverse the induced hemolysis was 
mainly exhibited by SM-250 and CKV. The MCV 
level also increased in all the treatments over 
that of the controls. The status of the white blood 
cells and sICAM were restored by all treatments 
(Table 2). The S. monostachyus extracts had the 
ability to reverse hemolysis induced by 2BE, 
resulting in improved hematological parameters 
(i.e., PCV, RBC, MCV and hemoglobin) in this 
study [ 9,23,32]. The fact that our treatments had 
no effect on the white blood cell level is in line 
with previous reports indicating that 2-BE 
principally affects RBCs [33,34]. The ability of the 
plant extracts to cure hemolysis manifested as 
increased hematologic parameters in the blood 
of the treated animals [12]. S. monostachyus 
contains moderate cardiac glycosides that may 
be responsible for the curative effects on 
hemolysis and other diseases associated with 
the heart, as reported previously [17,35]. 
 
Bilirubin is a product of heme catabolism and a 
potent antioxidant in biological systems [36,37]. It 
is metabolized to biliverdin, which is 
subsequently metabolized by heme oxygenase 
[38,39]. 
 
The total bilirubin level of the CKV group 
increased in the spleen over that of the controls 
and other treatment groups. Additionally, bilirubin 
was increased in the liver by 2BEA, CF-A, SM-
250 and CKV to a greater extent than in the 
control group, while SM-150 and SM-200 
decreased the bilirubin levels in the liver. In the 
kidney, similar increased bilirubin levels were 
manifested by the CKV group, while decreased 
bilirubin levels were observed in the other groups 
relative to the controls (Table 3). The increased 
levels of bilirubin resulting from the 
administration of CKV in all the organs and CF-A 
and SM-250 in the liver, indicate the ability of 
these treatments to reduce stress, whereas the 
administration of SM-150 and SM-200 tended to 
increase stress, mainly in the liver. This may be 
because of the availability of more antioxidants at 
the highest concentration (i.e., SM-250) of S. 
monostachyus [38,39,40,41]. SM-200, SM-250 
and CKV treatments increased the level of direct 
bilirubin in the spleen (Table 5). Hence, S. 
monostachyus doses of 200–250 mg/kg of body 
weight may be capable of protecting the spleen 
from stress and other malignancies [40]. 
 
Lipid peroxidation is a well-established 
mechanism of cellular injury in both plants and 
animals and is used to indicate oxidative stress 
in cells and tissues. Lipid peroxides are unstable, 
and thus, they are liable to decompose and form 
a complex series of compounds, including
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Table 1. Table showing weight of animals the days of experiment 
 
Results Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 
C 96.3 109.4 107.4 103.6 105.4 102.1 109.4 107.6 117.4 
2BEA 104.6 116 116 107.6 114.3     
CF-A 102.3 114.6 105.6 101.4 107.7 109.4 117.1 113.9 119.7 
SM-150 95.42 102.7 100.9 98.6 106.4 98.3 106.7 109.1 113.4 
SM-200 108.4 139.4 126.7 125.1 124.9 122.3 142.1 133 142 
SM-250 97 104.1 102.1 103.1 103 100.6 115 105.9 106.3 
CKV 102.7 111.9 103.1 110.7 109.7 108.3 112.4 113.4 125 
 
Table 2. Table showing hematology analyses and sIcam result 
 
 C 2BEA CF-A SM-150 SM-200 SM-250 CKV 
PCV (%) 38.0±2.89 44.44±2.30
a,f,g 
43.0±3.06
a 
42.4±3.31
a 
47.5±1.87
a,b,c,d,f,g 
39.9±2.61 40.4±2.30 
Hb (g/dl) 12.89±1.04 14.53±1.09a,f 14.30±0.93a,f 14.30±1.08a,f 15.50±0.85a,c,d,f,g 13.20±0.57 13.76±0.75 
RBC/ml 4.26±0.29 4.84±0.28
a 
4.77±0.36
a 
4.71±0.36
a 
5.30±0.20
a,b,c,d,f,g 
4.41±0.30 4.53±0.29 
MCV (fL) 76.86±3.840 91.79±2.474 90.10±1.456 89.81±0.558 89.52±0.866 90.20±0.529 89.04±1.367 
WBC/ml 7000.0±1655.29 6100.0±2221.11 6614.3±1038.31 6500.0±1721.43 6616.7±1231.94 6500.0±1800.00 6885.7±819.41 
sICAM (ng/g) 2.90±0.32 3.00±0.12 3.12±0.41 3.12±0.21 3.13±0.42 3.02±0.42 3.00±0.38 
Values expressed in mean ± sd; n=7 values in each column with different superscripts (a-g) are significantly different (p = .05) 
 
Table 3. Effect of oral administration extract of Solenostanum monostachyus plant extract on some oxidative stress parameters in the liver 
 
Parameters C 2BEA CF-A SM-150 SM-200 SM-250 CKV 
SOD 68.61±15.62 68.13±5.98 57.59±13.69 59.11±7.61 71.73±6.63 70.53±7.30 62.14±10.32 
TBARS 
(nmol/gtissue) 
3.89±0.76 6.04±1.93 4.74±0.80 5.96±1.27 7.85±2.48 6.12±2.23 4.94±1.31 
PEROXIDASE 
(Unit/ml) 
4.92±1.89 3.71±1.78 4.64±2.28 5.76±3.60 4.50±1.48 4.11±1.23 6.32±1.37 
GSH 
(mmol/g tissue) 
4.14±0.65 13.75±11.05 3.45 ±0.49 4.27 ±0.47 3.92 ±1.20 4.57 ±1.32 10.91±8.05 
BILIRUBIN 1.43±0.34 1.47±0.36 1.98±0.64 1.29±0.63 0.80±0.59 1.49±0.62 1.59±0.37 
Values expressed in mean± sd, n=4 
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Table 4. Effect of oral administration extract of Solenostanum monostachyus plant extract on some oxidative stress parameters in the kidney 
 
Parameters C 2BEA CF-A SM-150 SM-200 SM-250 CKV 
SOD (Unit/ml) 47.92±13.98 51.76±9.96 54.15±2.86 53.51±7.59 32.03±21.16 43.37±10.48 54.31±7.23 
TBARS (nmol/g tissue)   4.49±1.20  2.56±0.29 3.93±1.48    13.89±16.40   4.58±1.21   7.71±1.87 4.55±1.13   
PRX (Unit/ml) 3.71±1.00 3.30±1.73 2.31±0.91 258.99±674.82 3.63±1.71 2.23±0.66 2.85±0.53 
GSH (mmol/g tissue) 0.007±0.001  0.009±0.001 a,c,d,e,f 0.008±0.001c,d,e,f 0.007±0.001  0.007±0.001   0.006±0.001 0.011±0.001a,b,c,d,e,f 
BILIRUBIN 1.37±0.42 1.13±0.22 1.25±0.21 1.21±0.35 0.86±0.50 1.13±0.29 1.60±0.51 
Values expressed in mean ± sd; n=4. Values in each column with different superscripts (a-f) are significantly different (p = .05)  
 
Table 5. Effect of oral administration extract of Solenostanum monostachyus plant extract on some oxidative stress parameters in the spleen 
 
Parameters C 2BEA CF-A SM-150 SM-200 SM-250 CKV 
SOD 76.76±7.73 98 77.56±10.14 79.71±10.57 81.15±7.26 78.43±6.56 73.32±5.21 78.19±8.25 
TBARS (nmol/g tissue)  3.78±1.141   5.11±0.56   4.97±1.16   3.46±1.38   3.38±1.35   3.24±0.84   3.33±0.79   
PEROXIDASE (Unit/ml) 3.20±0.97 4.31±1.66 3.14±1.49 4.87±4.58 4.90±2.37 5.67±6.43 4.04±1.36 
GSH (mmol/g tissue) 4.87±1.08  7.85±2.83
a,e,g 
5.47±1.07  7.67±2.19
a,e,g 
4.57±2.21  6.08±1.35   4.27±0.62  
BILIRUBIN 0.73±0.24   0.88± 0.14 1.09± 0.45 0.93± 0.34 1.12±0.52   1.14±0.22   1.14±0.22   
Values expressed in mean ± sd; n=4 values in each column with different superscripts (a-g) are significantly different (p = .05) 
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reactive carbonyl compounds [41]. 
Polyunsaturated fatty acid peroxides generate 
malondialdehyde (MDA) and 4-hydroxyalkenals 
(HAE) upon decomposition, which are used to 
indicate lipid peroxidation [42]. A decrease in 
thiobarbituric acid reactive substance (TBARS) 
suggests that the plant extract is rich in 
antioxidants able to neutralize the effects of free 
radical reactive species. 
 
The effects of the three extracts (i.e., SM-150, 
SM-200 and SM-250) and the other treatments 
(i.e., CF-A and CKV) on the oxidative stress 
parameters (i.e., TBARS, GSH, peroxidase, 
bilirubin and superoxide dismutase [SOD] 
activity) in the liver were not better than that of 
2BEA (Table 3). The results of bilirubin, GSH, 
TBARS, peroxidase activity and SOD activity in 
the kidney were comparable to those of the 
control group (Table 4). The integrity of TBARS, 
SOD activity and peroxidase activity in the 
spleen were restored by the extracts and other 
treatments (Table 5).  
 
GSH is a freely available antioxidant that acts 
directly as an antioxidant and facilitates the 
catalytic cycles of several antioxidant enzymes, 
such as glutathione peroxidase, glutathione 
reductase and glutahthione-S-transferase 
[43,44]. GSH activity was generally increased 
during hemolysis induced by 2BEA in the liver 
(Table 3), kidney (Table 4) and spleen (Table 5). 
An increase in GSH activity therefore indicates 
hemolysis in this study. A similar increase in 
GSH activity manifested in the spleen of the SM-
150 administered groups (Table 5). This implies 
that the concentration of the SM-150 extract was 
not able to provide sufficient antioxidants to 
prevent stress in the spleen. As expected, the 
hemolysis was cured by the anti-hemolytic and 
anti-sickling drug (i.e., CKV), which was able to 
reduce GSH activity in the kidney (Table 4). The 
other extracts with higher concentrations (i.e., 
SM-200 and SM-250), including CF-A, mainly 
restored the integrity of the spleen by restoring 
the antioxidant status that was degraded during 
the induced hemolysis. The antioxidant 
properties of phenolic acids, such as caffeic acid, 
enhance their protective effects [45]. Thus, S. 
monostachyus extract at 200–250 mg/kg of body 
weight, CF-A and CKV are good inhibitors of the 
oxidative stress associated with hemolysis 
[12,46]. 
 
5. CONCLUSION 
 
In conclusion, this study revealed that S. 
monostachyus dosages of 150–200 mg/kg of 
body weight were most appropriate for treating 
hemolytic anemia-related diseases, such as 
SCD, because such treatments enhanced or 
restored the hematological and inflammatory 
activities and oxidative stress parameters. In the 
future, the molecular effects of the plant extract 
at these doses (150–200 mg/kg of body weight) 
should be investigated by sequencing the 
affected genes to further understand the 
therapeutic mechanism of action against 
hemolytic-related diseases. 
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